You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
九洲藥業(603456.SH)2020年度淨利潤預增55%到70% 受益於CDMO的增長
格隆匯 01-27 16:32

格隆匯 1 月 27日丨九洲藥業(603456.SH)公佈,經財務部門初步測算,公司預計2020年年度實現歸屬於上市公司股東的淨利潤36858萬元到40425萬元,與上年同期相比,將增加13079元到16646同比增加55%70%歸屬於上市公司股東的扣除非經常性損益的淨利潤與上年同期相比,將增加9109萬元到12524萬元,同比增加40%55%

公司本期業績增長主要受益於CDMO業務的增長2020年公司持續加大CDMO業務板塊佈局,始終堅持以客户需求為導向,深度拓展客户管線及產品管線,穩步提升公司研發能力及產品交付能力。同時,公司與國內知名創新藥原研公司如NovartisRoche貝達藥業、華領醫藥達成深度嵌入式合作,公司CDMO業務持續穩健發展。

公司非經常性損益主要為政府補貼及遠期結售匯的影響,扣除所得税影響後的非經常性損益金額較上年同期增加4000萬元左右

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account